Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor-mediated gene delivery employing lectin-binding specificity

R K Batra1, F Wang-Johanning, E Wagner

  • 1University of North Carolina at Chapel Hill, School of Medicine, Department of Medicine, USA.

Gene Therapy
|July 1, 1994
PubMed
Summary

Gene therapy for cancer requires selective targeting. Researchers developed novel lectin-targeted molecular conjugate vectors for effective gene transfer, showing potential for cancer cell targeting in gene therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor.

Cancer gene therapy·2015
Same author

Gene therapy for radioprotection.

Cancer gene therapy·2015
Same author

Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer.

Cancer gene therapy·2014
Same author

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.

Cancer gene therapy·2014
Same author

Methods for Gene Transfer Using DNA-Adenovirus Conjugates.

Methods in molecular medicine·2014
Same author

Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor.

Cancer gene therapy·2013

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Selective targeting of malignant cells is crucial for effective cancer gene therapy.
  • Gene therapy strategies often rely on targeting differences between normal and cancerous cells.
  • Cell surface carbohydrates and their differential expression present a potential targeting mechanism.

Purpose of the Study:

  • To investigate the feasibility of using molecular conjugate vectors for targeted gene delivery to cancer cells.
  • To explore the potential of lectin binding specificities for distinguishing and targeting malignant cells.
  • To demonstrate gene transfer capabilities of novel lectin-targeted molecular conjugate vectors.

Main Methods:

  • Development of molecular conjugate vectors utilizing lectins.

Related Experiment Videos

  • Exploitation of differences in cell surface carbohydrate expression for targeting.
  • Assessment of gene transfer efficiency using lectin-targeted vectors.

    • Main Results:

    • Successful gene transfer was achieved using the novel lectin-targeted molecular conjugate vectors.
    • Lectin binding specificities were demonstrated to mediate cell binding.
    • The study confirmed the feasibility of targeting cancer cells via their unique glycocalyx.

    Conclusions:

    • Lectin-targeted molecular conjugate vectors represent a novel approach for cancer cell targeting in gene therapy.
    • Differential expression of cell surface carbohydrates can be exploited for selective gene delivery.
    • These findings support the potential application of this targeting strategy in future cancer gene therapy development.